Mammoth Biosciences
Leann Teadt is a Senior Scientist at Mammoth Biosciences since September 2024, bringing a rich background in biomolecular chemistry. Prior experience includes serving as a Scientist at Codexis, Inc. from July 2018 to September 2024 and completing a PhD in Biomolecular Chemistry at Emory University, where Leann was a Graduate Student from August 2012 to March 2018. Academic credentials include a Bachelor's Degree in Chemistry from Carthage College, earned between 2008 and 2012.
This person is not in any teams
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.